Burcon NutraScience Corporation

Burcon reported Q1 revenue of $1.3 million, up 54% quarter over quarter and over threefold versus the prior-year quarter. Alex Varty said the company generated a 7% decrease in operating loss quarter over quarter, helped by revenue growth and a focus on production. Management also announced a convertible debenture financing for gross proceeds of up to $8.1 million, with proceeds intended for labor, inventory, production capability, future capacity planning, efficiency improvements, debt repayment, and working capital. Looking ahead, Kip Underwood said Burcon expects double-digit revenue by the end of the calendar year and to become cash flow positive during the calendar year; he also said capacity expansion should be in place for calendar Q4 and calendar Q1 of '27.

Kip Underwood framed the quarter as proof that Burcon’s technology is commercially relevant and increasingly validated by repeat customer purchases. He emphasized a broad protein-demand backdrop, including GLP-1-driven nutrition needs, and said Burcon’s unmatched purity helps food companies deliver higher protein without sacrificing taste. His tone was confident and growth-oriented, repeatedly saying the company is 'executing the plan' while investing for future demand.

Alex Varty highlighted the financial momentum from scaling the Galesburg facility, pointing to $1.3 million of revenue, 54% sequential growth, and more than a threefold increase year over year. He said operating loss improved 7% quarter over quarter and tied that to disciplined spending on production and revenue generation. On capital allocation, he said the up-to-$8.1 million financing is expected to support growth investments, debt retirement, and working capital, and that the structure should strengthen the balance sheet and capital structure.

Analysts asked about the customer funnel, the mix of testing versus repeat buyers, and which product categories are leading growth; management said the base is diversified across food types, customer sizes, and the full product portfolio, with strong traction in beverages, powder mixes, nutrition bars, snacks, and plant-based foods. On the financing, management said the close is expected shortly after the September 16 Annual Shareholder Meeting, likely in late September or early October, and that the proceeds are intended entirely for growth-related uses. On GLP-1 adoption, Underwood said Burcon is in the 'first inning' of a long growth trend, with U.S. penetration still in the high single digits, and said the company is focused on North America despite seeing potential in Europe.